NVNO (enVVeno Medical Corporation Common Stock) Stock Analysis - AI Report
enVVeno Medical Corporation Common Stock (NVNO) is a publicly traded Healthcare sector company. As of May 21, 2026, NVNO trades at $10.95 with a market cap of $6.56M and a P/E ratio of -0.30. NVNO moved -1.77% today. Year to date, NVNO is -10.61%; over the trailing twelve months it is -91.38%. Its 52-week range spans $8.67 to $196.70. Rallies surfaces NVNO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on NVNO?
Rallies AI research for NVNO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Duhay Francis sold 4.90K (~$1.74K) on Dec 11, 2025.
Duhay Francis sold 4.90K (~$4.07K) on Sep 15, 2025.
NVNO Analyst Consensus
NVNO analyst coverage data. Average price target: $0.00.
Common questions about NVNO
What is the AI research view on NVNO?
Rallies AI research for NVNO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for NVNO?
Rallies AI research for NVNO combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is NVNO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NVNO. It does not provide personalized investment advice.
